Gene Panel Market Report 2026

Gene Panel Market Overview

• Gene Panel market size has reached to $2.47 billion in 2025 • Expected to grow to $4.96 billion in 2030 at a compound annual growth rate (CAGR) of 14.9% • Growth Driver: Growing Cancer Prevalence Driving Expansion Of The Market • Market Trend: Advancements In Oncology Panels Enhancing Cancer Diagnostics And Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gene Panel Market?

Gene panels refer to a collection of specific genes selected for testing in a single assay to assess genetic variations related to particular diseases or conditions. They are used for diagnosing genetic disorders, identifying inherited diseases, and providing personalized treatment plans by analyzing multiple genes simultaneously, often in the context of cancer, rare diseases, or other genetic conditions. The main types of gene panel products and services are test kits and testing services. Test kits are pre-packaged tools that include all the necessary reagents and instructions for conducting genetic analysis. It uses various technologies, such as amplicon-based, hybridization-based, and others, and it can be both predesigned and customized. It is applied for cancer risk assessment, diagnosis of congenital diseases, pharmacogenetics, and others and is used by various end users, including research institutes, hospitals, diagnosis centers, pharmaceutical companies, and others.

What Is The Gene Panel Market Growth Forecast?

The gene panel market size is expected to see rapid growth in the next few years. It will grow to $4.96 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to growth in personalized medicine, expansion of hereditary disease testing, demand for precision diagnostics, integration of ai in genomic analysis, wider clinical adoption. Major trends in the forecast period include growing adoption of multi-gene diagnostic panels, increased use in cancer risk assessment, expansion of customized gene panel testing, rising demand for pharmacogenomic insights, integration of gene panels in clinical decision-making.

Global Gene Panel Market Segmentation

1) By Product And Services: Test Kits, Testing Services 2) By Technology: Amplicon-Based, Hybridization-Based, Other Technologies 3) By Design: Predesigned Gene Panel, Customized Gene Panel 4) By Application: Cancer Risk Assessment, Diagnosis Of Congenital Diseases, Pharmacogenetics, Other Applications 5) By End-User: Research Institutes, Hospital, Diagnosis Centers, Pharmaceutical Companies, Other End-Users Subsegments: 1) By Test Kits: Predesigned Gene Panels, Customized Gene Panels 2) By Testing Services: Cancer Risk Assessment Panels, Pharmacogenetic Testing Panels, Neurological Disorder Panels, Cardiovascular Disease Panels, Rare Disease Panels

What Is The Driver Of The Gene Panel Market?

The increasing prevalence of cancer is expected to propel the growth of the gene panel market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can invade and damage surrounding tissues and organs. Cancer cases are rising due to factors such as aging populations, lifestyle changes, environmental exposures, and improved detection and diagnostic technologies. Gene panels help in cancer by enabling comprehensive genetic testing to identify mutations and alterations in specific genes, which can guide personalized treatment strategies and improve outcomes for cancer patients. For instance, in January 2023, according to the PubMed, a US-based free search engine for biomedical and life sciences literature maintained by the United States National Library of Medicine, reported that in 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Therefore, the increasing prevalence of cancer is driving the growth of the gene panel industry.

Key Players In The Global Gene Panel Market

Major companies operating in the gene panel market are F. Hoffmann-La Roche, Thermo Fisher Scientific, Quest Diagnostics, Eurofins Scientific, Agilent Technologies, Illumina, Qiagen, Myriad Genetics, Guardant Health, Invitae, Integrated DNA Technologies, Bio-Rad, Novogene, Fulgent Genetics, MedGenome, Centogene, Blueprint Genetics, BIONEER, BGI Group.

Global Gene Panel Market Trends and Insights

Major companies operating in the gene panel market are focusing on developing innovative technologies, such as oncology panels, to enhance the accuracy, efficiency, and comprehensiveness of cancer diagnostics and personalized treatment strategies. Oncology panels are specialized gene panels that analyze multiple genes associated with cancer to identify genetic mutations and alterations, aiding in the diagnosis, prognosis, and treatment of cancer. For instance, in May 2023, Vizgen Inc., a US-based biotechnology company, launched the MERFISH PanCancer Pathways Panel, offering a customizable option for scientists entering the field of spatial genomics. These predesigned panels are tailored for various research applications, including cancer studies, and are optimized for enhanced error robustness, providing reliable and reproducible results. By integrating spatial information with gene expression data, the panels offer deeper insights into tumor microenvironments and cellular interactions, facilitating more targeted and personalized cancer research and therapeutic development. This launch represents a significant advancement in spatial biology, enabling researchers to explore complex biological systems with a level of detail previously unattainable.

What Are Latest Mergers And Acquisitions In The Gene Panel Market?

In May 2025, GeneDx Holdings Corp., a US-based provider of clinical genetic and genomic diagnostic testing, acquired Fabric Genomics for an undisclosed amount. With this acquisition, GeneDx aims to enhance its gene-panel testing capabilities and integrate AI-powered genomic interpretation to improve diagnostic accuracy and scale its services globally. Fabric Genomics is a US-based provider of AI-driven genomic interpretation software, offering tools that analyze genetic sequencing data and assist clinical laboratories in identifying disease-causing variants.

Regional Outlook

North America was the largest region in the gene panel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gene Panel Market?

The gene panel market consists of revenues earned by entities by providing services such as custom panel design, next-generation sequencing, bioinformatics analysis, clinical interpretation, and pharmacogenomics services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene panel market also includes sales of metabolic disorder panels, reproductive health panels, carrier screening panels, and neurological disorder panels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gene Panel Market Report 2026?

The gene panel market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gene panel industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.